MSN Group launches Vigabatrin Powder for Oral Solution for treatment of infantile spasm (epilepsy) under the brand name VIGANEXTTM
Mumbai, 17 November 2021 (GPN): Subsequent to the successful launch of its third generation anti-epileptic drug, BRIVANEXT™, MSN Labs has announced the launch of yet another anti-epileptic and India’s first generic Vigabatrin Powder for Oral…